Coding and noncoding GATA2 mutations cause GATA2-deficiency syndromes, which often involve immunodeficiency and predisposition to develop myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) (15, 44, –, 48). This evidence concerns the gene GATA2 and immunodeficiency disease.